Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Intangibles (2022 - 2025)

Coeptis Therapeutics Holdings (COEP) has 4 years of Intangibles data on record, last reported at $406406.0 in Q3 2025.

  • For Q3 2025, Intangibles changed N/A year-over-year to $406406.0; the TTM value through Sep 2025 reached $406406.0, changed N/A, while the annual FY2024 figure was $541875.0, N/A changed from the prior year.
  • Intangibles reached $406406.0 in Q3 2025 per COEP's latest filing, down from $451563.0 in the prior quarter.
  • Across five years, Intangibles topped out at $3.6 million in Q4 2022 and bottomed at $406406.0 in Q3 2025.
  • Average Intangibles over 4 years is $1.8 million, with a median of $1.7 million recorded in 2023.